Babu Naidu

University of Birmingham

Papers

1

Total Citations

88

H-Index

1

About

Babu Naidu is a leading thoracic surgeon and researcher whose work has fundamentally shaped the evidence base for minimally invasive lung cancer surgery. His primary research areas include video-assisted thoracoscopic surgery (VATS), perioperative recovery, and patient-reported outcomes in thoracic oncology. Naidu’s most significant contribution is his leadership of the landmark VIOLET RCT, which definitively compared VATS lobectomy to open lobectomy for lung cancer. This pivotal trial demonstrated that VATS significantly improves early recovery, as measured by self-reported physical function, without compromising oncologic outcomes. With 88 citations since 2022, the VIOLET trial has become a cornerstone reference, directly influencing surgical guidelines and practice worldwide. Beyond this, Naidu has advanced understanding of enhanced recovery pathways and risk stratification in thoracic surgery. His work is distinguished by rigorous methodology and a patient-centered focus, translating complex surgical questions into actionable clinical evidence. For students and researchers, Naidu exemplifies how a single, well-designed trial can transform a field, proving that less invasive approaches can deliver better recovery while maintaining surgical efficacy.

Research Focus

Key Achievements

1
H-Index
1
Papers
88
Total Citations
88
Avg Citations/Paper
🏆 Most Cited Paper
Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT
88 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: University of Birmingham

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago